Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

Doses of the COVID-19 vaccine purchased through the federally funded Vaccines for Children program only started arriving this ...

The market for VZV infection treatment is driven by increased vaccination and antiviral use, rising elderly populations, and strong immunization programs in developed regions. Key opportunities ...

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

Key Points Sold entire holding of 109,630 shares; estimated trade value of approximately $2.66 million based on the quarterly average price Stake was previously 1.2% of fund AUM as of the prior ...

After a chaotic year that has seen the attrition of over half the FDA’s senior leadership, many of these individuals have ...

The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and ...

Trump got his COVID and flu shots last week. That's a good thing. But it's wrong that misinformation and confusion about ...

It comes as more than 1,000 suspected adverse reactions to Covid vaccines have been reported in the Isle of Man, including ...